Cure not kill: Dynamite ingredient can improve cancer treatment says study
Nitroglycerin could make cancer drugs more effective say researchers trying to use the dynamite ingredient to help destroy tumours.
Archives for August 26, 2015
Novo Nordisk to pump $2bn into diabetes network on back of oral GLP-1 milestone
Novo Nordisk could spend up to $2bn (€1.8bn) on two facilities to support its diabetes portfolio, including an oral long-acting GLP-1 analogue set to enter Phase III trials.
To supply the Dane: Novo expects First API batch in 2020
Novo Nordisk has confirmed it will build an API plant in the US, telling this publication a desire to have manufacturing capacity in the key market for its oral diabetes candidate, semaglutide, drove the decision.
Scientists build ‘microfish’ robots for controlled drug delivery
US researchers say 3-D printed microscopic fish robots will allow intelligent drug delivery.
Europe, US, Japan: The recall round-up
Product problems for Allergan and Danish Leo Pharma, plus the Japanese regulator reviews a Bristol-Myers Squibb mAb.
Mid-sized M&A madness: Smaller deals dominate CRO space so far in 2015
Chiltern’s takeover of Theorem Clinical will be the latest acquisition in a busy eight months of deals impacting the mid-sized CRO space.
MHRA uncovers $1m illegal ED drug haul
A UK man has been sentenced to 16 months in prison for smuggling illegal erectile dysfunction drugs following an MHRA investigation.